Geneva-Popova Mariela, Popova-Belova Stanislava, Popova Velicka, Stoilov Nikolay
Department of Propedeutic of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, Clinic of Rheumatology, University General Hospital "Sveti Georgi", 4001 Plovdiv, Bulgaria.
Department of Propedeutic of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, University General Hospital "Kaspela", 4001 Plovdiv, Bulgaria.
Diagnostics (Basel). 2022 May 18;12(5):1260. doi: 10.3390/diagnostics12051260.
Background: This study examines the relationship between the presence of crystals in the synovial fluid of patients with psoriatic arthritis (PsA) and disease activity. Methods: The synovial fluid of 156 PsA patients was analyzed and compared to 50 patients with gonarthrosis (GoA). The Leica DM4500P polarization microscope was used for crystal detection. Results: The presence of crystals was observed in 23.71% of PsA patients and none of the GoA patients, p < 0.001. Monosodium urate crystals (67.58%) and calcium pyrophosphate crystals (21.62%) were prevalent. The presence of crystals in the synovial fluid of PsA patients was associated with high disease activity according to the Composite Psoriatic Disease Activity Index (OR = 18.75, 95%; CI: 7.13 to 49.25) and the Disease Activity for Psoriatic Arthritis (OR = 15.96, 95%; CI: 5.76 to 44.23), with severe disability according to the Health Assessment Questionnaire Disability Index (OR = 13.60, 95%; CI: 5.09 to 36.31), and with severe pain on the Visual Analog Scale (OR = 157.25, 95%; CI: 39.50 to 625.94). Conclusion: Our results suggest that synovial fluid examination should be included in the treatment pathway for PsA patients with active disease, to aid in determining whether urate-lowering therapy is required.
本研究探讨银屑病关节炎(PsA)患者滑液中晶体的存在与疾病活动度之间的关系。方法:分析156例PsA患者的滑液,并与50例膝骨关节炎(GoA)患者进行比较。采用徕卡DM4500P偏振显微镜进行晶体检测。结果:PsA患者中23.71%存在晶体,而GoA患者中无一例存在晶体,p<0.001。尿酸钠晶体(67.58%)和焦磷酸钙晶体(21.62%)较为常见。根据银屑病综合疾病活动指数(OR=18.75,95%;CI:7.13至49.25)和银屑病关节炎疾病活动度(OR=15.96,95%;CI:5.76至44.23),PsA患者滑液中晶体的存在与高疾病活动度相关;根据健康评估问卷残疾指数(OR=13.60,95%;CI:5.09至36.31),与严重残疾相关;根据视觉模拟量表(OR=157.25,95%;CI:39.50至625.94),与严重疼痛相关。结论:我们的结果表明,对于疾病活动的PsA患者,滑液检查应纳入治疗流程,以帮助确定是否需要降尿酸治疗。